Is FCAGX or JNJ a better dividend investment in 2026?

FCAGX currently yields 9.17% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: FCAGX offers higher current income.

What is the dividend yield difference between FCAGX and JNJ?

FCAGX has a forward dividend yield of 9.17% ($2.92/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 5.81 percentage points.

Home › Compare › FCAGX vs JNJ

FCAGX vs JNJ: Dividend Comparison 2026

FCAGX yields 9.17% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 FCAGX wins by $16.7K in total portfolio value

INVESTMENT

TIME HORIZON10 years

FCAGX

● Live price

9.17%

Share price

$31.86

Annual div

$2.92

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$36.7K

Annual income

$1,634.78

Full FCAGX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — FCAGX vs JNJ

📍 FCAGX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	FCAGX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, FCAGX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

FCAGX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FCAGX

Annual income on $10K today (after 15% tax)

$779.57/yr

After 10yr DRIP, annual income (after tax)

$1,389.56/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, FCAGX beats the other by $685.95/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FCAGX + JNJ for your $10,000?

FCAGX: 50%JNJ: 50%

100% JNJ50/50100% FCAGX

Portfolio after 10yr

$28.4K

Annual income

$1,231.28/yr

Blended yield

4.34%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FCAGX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FCAGX buys

JNJ buys

No recent congressional trades found for FCAGX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricFCAGXJNJ

Forward yield	9.17% ✓	3.36%
Annual dividend / share	$2.92	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$36.7K ✓	$20.0K
Annual income after 10y	$1,634.78 ✓	$827.78
Total dividends collected	$12.8K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: FCAGX vs JNJ ($10,000, DRIP)

Year	FCAGX Portfolio	FCAGX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,617	$917.14	$10,676	$355.77	+$941.00 → FCAGX
2	$13,426	$995.75	$11,407	$389.39	+$2.0K → FCAGX
3	$15,441	$1,075.51	$12,198	$426.53	+$3.2K → FCAGX
4	$17,678	$1,156.03	$13,056	$467.62	+$4.6K → FCAGX
5	$20,153	$1,236.92	$13,987	$513.12	+$6.2K → FCAGX
6	$22,881	$1,317.80	$14,998	$563.56	+$7.9K → FCAGX
7	$25,881	$1,398.34	$16,098	$619.52	+$9.8K → FCAGX
8	$29,171	$1,478.20	$17,295	$681.69	+$11.9K → FCAGX
9	$32,770	$1,557.11	$18,599	$750.82	+$14.2K → FCAGX
10	$36,699	$1,634.78	$20,022	$827.78	+$16.7K → FCAGX

FCAGX vs JNJ: Complete Analysis 2026

FCAGX — Stock

The investment seeks capital appreciation. The fund invests primarily in common stocks. It invests at least 80% of its assets in securities of companies with small market capitalizations. The fund invests in companies that Fidelity Management & Research Company (FMR) believes have above-average growth potential (stocks of these companies are often called "growth" stocks). It invests in domestic and foreign issuers. The fund uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments.

Full FCAGX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this FCAGX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FCAGX vs SCHD FCAGX vs JEPI FCAGX vs O FCAGX vs KO FCAGX vs MAIN FCAGX vs ABBV FCAGX vs MRK FCAGX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.